Sandra Allen-Bard discusses her passion for advocacy involvement with the Leukemia & Lymphoma Society.
Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses her involvement in advocacy groups.
Working as a nurse for patients with leukemia for over 20 years, Allen-Bard has gained a passion in seeing how life-altering this diagnosis can be. She believes that research needs to continue as there are different pathways to discover. With the Leukemia & Lymphoma Society, Allen-Bard can use her running, education, and her voice to help her patients in just one more way.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.